Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists
    1.
    发明授权
    Method for treating insulin sensitivity by long-acting GLP-1 receptor mimetibody agonists 有权
    用长效GLP-1受体模拟体激动剂治疗胰岛素敏感性的方法

    公开(公告)号:US07833531B2

    公开(公告)日:2010-11-16

    申请号:US11962214

    申请日:2007-12-21

    IPC分类号: A61K39/00 A61K38/00 C07K16/00

    CPC分类号: A61K38/26 G01N2800/044

    摘要: The present invention provides to at least one novel human GLP-1 receptor agonist, or specified portion or variant, including isolated nucleic acids that encode at least one GLP-1 receptor agonist, or specified portion or variant, GLP-1 receptor agonist, or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including the use of long acting GLP-1 receptor agonists to improve insulin sensitivity or lipid profiles in obesity and related therapeutic and/or diagnostic compositions, methods and devices.

    摘要翻译: 本发明提供至少一种新型人GLP-1受体激动剂或特定部分或变体,包括编码至少一种GLP-1受体激动剂或特定部分或变体GLP-1受体激动剂的分离核酸,或 特定部分或变体,载体,宿主细胞,转基因动物或植物,及其制备和使用方法,包括使用长效GLP-1受体激动剂来改善肥胖中的胰岛素敏感性或脂质分布以及相关的治疗和/或诊断 组合物,方法和装置。

    USE OF LONG-ACTING GLP-1 RECEPTOR AGONISTS TO IMPROVE INSULIN SENSITIVITY AND LIPID PROFILES
    2.
    发明申请
    USE OF LONG-ACTING GLP-1 RECEPTOR AGONISTS TO IMPROVE INSULIN SENSITIVITY AND LIPID PROFILES 有权
    使用长效GLP-1受体激动剂来提高胰岛素敏感性和脂质谱

    公开(公告)号:US20090098108A1

    公开(公告)日:2009-04-16

    申请号:US11962214

    申请日:2007-12-21

    CPC分类号: A61K38/26 G01N2800/044

    摘要: The present invention provides to at least one novel human GLP-1 receptor agonist, or specified portion or variant, including isolated nucleic acids that encode at least one GLP-1 receptor agonist, or specified portion or variant, GLP-1 receptor agonist, or specified portion or variants, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, including the use of long acting GLP-1 receptor agonists to improve insulin sensitivity or lipid profiles in obesity and related therapeutic and/or diagnostic compositions, methods and devices.

    摘要翻译: 本发明提供至少一种新型人GLP-1受体激动剂或特定部分或变体,包括编码至少一种GLP-1受体激动剂或特定部分或变体GLP-1受体激动剂的分离核酸,或 特定部分或变体,载体,宿主细胞,转基因动物或植物,及其制备和使用方法,包括使用长效GLP-1受体激动剂来改善肥胖中的胰岛素敏感性或脂质分布以及相关的治疗和/或诊断 组合物,方法和装置。